Nature Wins over Pharmaceuticals – Palmitoylethanolamide

Nature Wins over Pharmaceuticals – Palmitoylethanolamide

A natural medicine turns out to be better than pharmaceuticals developed by the pharmaceutical industry!

World Pain Congress on Pharmaceuticals vs PEA

During the 14th world congress on pain, late August 2012, professor Di Marzo, world famous pharmacologist specializing in pain, made a captivating plea. There were thousands of people in the audience, including doctors and pain specialists.

He presented new data proving the painkillers the pharmaceutical industry has developed over the last years, are less attractive than the natural pain reliever palmitoylethanolamide.

Vicenzo Di Marzo discussed information that proved that the new pharmaceutical medicines, meant to inhibit the enzyme FAAH, are too nonspecific. By inhibiting the FAAH enzyme not only do they have the desired effect of raising the levels of palmitoylethanolamide in the body, they also decrease the level of substances responsible for causing pain.

What does that mean?

First of all, palmitoylethanolamide is an endogenous substance produced by the body to protect itself from pain and inflammation. The mentioned FAAH enzyme degrades palmitoylethanolamide very efficiently and thus decreases its pain-relieving and anti-inflammatory effects.

Anything that inhibits FAAH automatically makes palmitoylethanolamide, as well as some other similar molecules (such as anandamide) far more efficient. These molecules are naturally present in the body and completely safe, so by increasing their presence, the body is able to defend itself more efficiently.

This is a thrilling discovery that makes room for far more improvements, especially having in mind the various natural benefits of palmitoylethanolamide.

But there’s more

Studies conducted over the period of more than 60 years have proven the benefits of palmitoylethanolamide not only on reducing pain, but also on dealing with the sources of numerous neuropathic conditions and bad inflammatory reactions.

Recent discoveries add even more benefits through the endocannnabinoid system but also outside of it. The list of receptors that palmitoylethanolamide affects reveals a great variety of benefits.

Lastly, having more palmitoylethanolamide also means that FAAH can’t degrade it as quickly and palmitoylethanolamide is completely safe in any amounts.

It is an exciting prospect for anyone suffering from chronic pain and inflammation and also a very good way of doing away with the negative effects of pharmaceuticals.